In the last three months, 715 cases have been reported from
24 countries and areas. Over the past 4 weeks, 246
cases of mpox have been identified from 20 countries and
areas.
Since 7 March 2022, a total of 28 872 cases of mpox (formerly named
monkeypox) have been identified through IHR mechanisms, official public
sources and The European Surveillance System (TESSy) up to 14 January
2025, 14:00, from 47 countries and areas throughout the WHO European
Region. Case-based data were reported for 28 632
cases from 42 countries and areas to ECDC and the WHO Regional Office
for Europe through TESSy, up to 14 January 2025, 10:00. Of the 28 632
cases reported in TESSy, 28 446 were laboratory confirmed.
The majority of cases were male
(98%; n = 28 551) with the
most affected age group being 31–40 years-old
(39%; n = 28 588). Of the
12 872 male cases with known sexual behaviour, 97% were reported as men
who have sex with men. Among cases with known HIV status, 37%
(n = 12 149) were HIV-positive.
The majority of cases presented with a rash
(91%; n = 10 203). Systemic symptoms
such as fever, fatigue, muscle pain, chills, or headache were present in
53% of cases (n = 10 203).
There were 941 cases hospitalised (7%), of which
303 cases required clinical care. Nine cases were admitted to ICU, and 9
cases were reported to have died.
Since August 2024, 16 cases of clade 1b have been detected in
5 countries. All these cases either travelled themselves or are close
contacts of travelers from countries with known local transmission of
clade Ib.
An overview of the global situation can be found here: https://worldhealthorg.shinyapps.io/mpx_global/.
Copyright statement and
disclaimers
Users are advised to interpret all data with caution and be aware of
their limitations. Case counts and their corresponding data may have
monthly updates that include historical corrections as new information
is collected and reported.
The designations employed and the presentation of the material in
this publication do not imply the expression of any opinion whatsoever
on the part of WHO or ECDC concerning the legal status of any country,
territory, city or area or of its authorities, or concerning the
delimitation of its frontiers or boundaries.
The mention of specific companies or of certain manufacturers’
products does not imply that they are endorsed or recommended by WHO or
ECDC in preference to others of a similar nature that are not mentioned.
Errors and omissions excepted, the names of proprietary products are
distinguished by initial capital letters.
All reasonable precautions have been taken by WHO and ECDC to verify
the information contained in this publication. However, the published
material is being distributed without warranty of any kind, either
expressed or implied. The responsibility for the interpretation and use
of the material lies with the reader. In no event shall WHO or ECDC be
liable for damages arising from its use.
Copyright, permissions and referencing:
The WHO Regional Office for Europe is responsible for the accuracy of
the Russian translation.
Suggested citation: European Centre for Disease Prevention and
Control/WHO Regional Office for Europe. Mpox, Joint Epidemiological
overview, 30 January 2025.
Tables and figures should be referenced: European Centre for Disease
Prevention and Control/WHO Regional Office for Europe. Mpox, Joint
Epidemiological overview, 30 January 2025.
© World Health Organization 2024.
© European Centre for Disease Prevention and Control 2024.
Some rights reserved. This work is available under the Creative
Commons Attribution- 4.0 International (CC BY-4.0 ; Creative
Commons — Attribution 4.0 International — CC BY 4.0. In any use of
this work, there should be no suggestion that WHO or ECDC endorse any
specific organization, products or services. The use of the ECDC or WHO
logo is not permitted. If you create a translation of this work, you
should add the following disclaimer along with the suggested citation:
“This translation was not created by the European Centre for Disease
Prevention and Control (ECDC) or by the World Health Organization (WHO).
ECDC and WHO are not responsible for the content or accuracy of this
translation. The original English edition shall be the binding and
authentic edition.”
Acknowledgments
We gratefully acknowledge the Nextstrain team, the authors,
originating and submitting laboratories of the genetic sequences and
metadata (NCBI
Genbank) for sharing their work.
